BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25027107)

  • 21. Omentin-1 exerts bone-sparing effect in ovariectomized mice.
    Xie H; Xie PL; Luo XH; Wu XP; Zhou HD; Tang SY; Liao EY
    Osteoporos Int; 2012 Apr; 23(4):1425-36. PubMed ID: 21755404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th22 Cells Promote Osteoclast Differentiation
    Miyazaki Y; Nakayamada S; Kubo S; Nakano K; Iwata S; Miyagawa I; Ma X; Trimova G; Sakata K; Tanaka Y
    Front Immunol; 2018; 9():2901. PubMed ID: 30619268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes : an in vitro and in vivo study.
    Chen Z; Cheng Z; Tang Z; Li M; Tang X; Zhang H; Sun L
    Clin Exp Rheumatol; 2023 Nov; 41(11):2151-2161. PubMed ID: 36995338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
    Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH
    Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
    BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
    Kotake S; Udagawa N; Takahashi N; Matsuzaki K; Itoh K; Ishiyama S; Saito S; Inoue K; Kamatani N; Gillespie MT; Martin TJ; Suda T
    J Clin Invest; 1999 May; 103(9):1345-52. PubMed ID: 10225978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation.
    Lavocat F; Osta B; Miossec P
    Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
    Rifas L; Arackal S; Weitzmann MN
    J Cell Biochem; 2003 Mar; 88(4):650-9. PubMed ID: 12577299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption.
    Blaschke M; Koepp R; Cortis J; Komrakova M; Schieker M; Hempel U; Siggelkow H
    Adv Clin Exp Med; 2018 Jan; 27(1):45-56. PubMed ID: 29521042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
    Hirayama T; Danks L; Sabokbar A; Athanasou NA
    Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
    Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
    J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.
    Ignatius A; Schoengraf P; Kreja L; Liedert A; Recknagel S; Kandert S; Brenner RE; Schneider M; Lambris JD; Huber-Lang M
    J Cell Biochem; 2011 Sep; 112(9):2594-605. PubMed ID: 21598302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis.
    Park YH; Kim HJ; Lee K; Choi Y; Heo TH
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1030-1036. PubMed ID: 31818460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.
    Kitaura H; Kimura K; Ishida M; Kohara H; Yoshimatsu M; Takano-Yamamoto T
    Clin Dev Immunol; 2013; 2013():181849. PubMed ID: 23762085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH
    J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
    Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTH differentially regulates expression of RANKL and OPG.
    Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA
    J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual Role of Cyanidin-3-glucoside on the Differentiation of Bone Cells.
    Park KH; Gu DR; So HS; Kim KJ; Lee SH
    J Dent Res; 2015 Dec; 94(12):1676-83. PubMed ID: 26350961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.